These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10640907)

  • 1. UCN-01, a protein kinase C inhibitor, inhibits endothelial cell proliferation and angiogenic hypoxic response.
    Kruger EA; Blagosklonny MV; Dixon SC; Figg WD
    Invasion Metastasis; 1998-1999; 18(4):209-18. PubMed ID: 10640907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-angiogenic activity of human endostatin is HIF-1-independent in vitro and sensitive to timing of treatment in a human saphenous vein assay.
    Macpherson GR; Ng SS; Forbes SL; Melillo G; Karpova T; McNally J; Conrads TP; Veenstra TD; Martinez A; Cuttitta F; Price DK; Figg WD
    Mol Cancer Ther; 2003 Sep; 2(9):845-54. PubMed ID: 14555703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mycobacterial iron chelator, desferri-exochelin, induces hypoxia-inducible factors 1 and 2, NIP3, and vascular endothelial growth factor in cancer cell lines.
    Chong TW; Horwitz LD; Moore JW; Sowter HM; Harris AL
    Cancer Res; 2002 Dec; 62(23):6924-7. PubMed ID: 12460908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.
    Zhong H; Chiles K; Feldser D; Laughner E; Hanrahan C; Georgescu MM; Simons JW; Semenza GL
    Cancer Res; 2000 Mar; 60(6):1541-5. PubMed ID: 10749120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors.
    Yamakawa M; Liu LX; Date T; Belanger AJ; Vincent KA; Akita GY; Kuriyama T; Cheng SH; Gregory RJ; Jiang C
    Circ Res; 2003 Oct; 93(7):664-73. PubMed ID: 12958144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of geldanamycin on HIF-1alpha mediated angiogenesis and invasion in prostate cancer cells.
    Alqawi O; Moghaddas M; Singh G
    Prostate Cancer Prostatic Dis; 2006; 9(2):126-35. PubMed ID: 16432534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of apoptosis in rat thymocytes by analogs of staurosporine: lack of direct association with inhibition of protein kinase C.
    Harkin ST; Cohen GM; Gescher A
    Mol Pharmacol; 1998 Oct; 54(4):663-70. PubMed ID: 9765509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel antiangiogenic anticancer activities of deguelin targeting hypoxia-inducible factor-1 alpha.
    Oh SH; Woo JK; Jin Q; Kang HJ; Jeong JW; Kim KW; Hong WK; Lee HY
    Int J Cancer; 2008 Jan; 122(1):5-14. PubMed ID: 17764071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-responsive element-mediated soluble Tie2 vector exhibits an anti-angiogenic activity in vitro under hypoxic condition.
    Jeong CH; Lee YM; Choi KS; Seong YR; Kim YJ; Im DS; Kim KW
    Int J Oncol; 2005 Jan; 26(1):211-6. PubMed ID: 15586242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to growth inhibitory and apoptotic effects of phorbol ester and UCN-01 in aggressive cancer cell lines.
    Blagosklonny MV; Dixon SC; Robey R; Figg WD
    Int J Oncol; 2001 Apr; 18(4):697-704. PubMed ID: 11251163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical Evaluation of Discorhabdins in Antiangiogenic and Antitumor Models.
    Harris EM; Strope JD; Beedie SL; Huang PA; Goey AKL; Cook KM; Schofield CJ; Chau CH; Cadelis MM; Copp BR; Gustafson KR; Figg WD
    Mar Drugs; 2018 Jul; 16(7):. PubMed ID: 30029505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
    Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R
    Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer.
    Salnikow K; Costa M; Figg WD; Blagosklonny MV
    Cancer Res; 2000 Oct; 60(20):5630-4. PubMed ID: 11059752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
    Forooghian F; Das B
    Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NS398 reduces hypoxia-inducible factor (HIF)-1alpha and HIF-1 activity: multiple-level effects involving cyclooxygenase-2 dependent and independent mechanisms.
    Zhong H; Willard M; Simons J
    Int J Cancer; 2004 Nov; 112(4):585-95. PubMed ID: 15382039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
    Blancher C; Moore JW; Robertson N; Harris AL
    Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.
    Rapisarda A; Uranchimeg B; Scudiero DA; Selby M; Sausville EA; Shoemaker RH; Melillo G
    Cancer Res; 2002 Aug; 62(15):4316-24. PubMed ID: 12154035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines.
    Blancher C; Moore JW; Talks KL; Houlbrook S; Harris AL
    Cancer Res; 2000 Dec; 60(24):7106-13. PubMed ID: 11156418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.